How to institute the low-FODMAP diet

被引:77
作者
Barrett, Jacqueline S. [1 ]
机构
[1] Monash Univ, Cent Clin Sch, Dept Gastroenterol, Level 6,99 Commercial Rd, Melbourne, Vic 3000, Australia
关键词
diet; FODMAPs; functional gastrointestinal disorder; irritable bowel syndrome; lactose; IRRITABLE-BOWEL-SYNDROME; GASTROINTESTINAL SYMPTOMS; MALABSORPTION; SENSITIVITY; GUIDELINES; SORBITOL; FRUCTOSE;
D O I
10.1111/jgh.13686
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A diet low in poorly absorbed, fermentable, short chain carbohydrates (FODMAPs) is an effective strategy to manage symptoms of irritable bowel syndrome (IBS). The diet has gained traction since its original description in Australia 10 years ago and is now an internationally accepted dietary management strategy for IBS. Randomized controlled trials have raised the profile of the low-FODMAP diet to become a viable first-line therapy for IBS, when implemented under a dietitian's guidance. Importantly, the diagnosis of IBS should be confirmed before commencement of the dietary approach. The skill set of the dietitian is then paramount to the success of the diet. Experience in gastrointestinal disorder management, consideration of symptom types, severity, baseline FODMAP intake, and overall nutritional content and meal pattern are vital in the assessment of the patient. If a strict low-FODMAP diet is deemed necessary, it should only be for an initial period of 4 to 6 weeks. Research suggests that a strict long-term, low-FODMAP diet may negatively impact intestinal microbiome. After the initial strict period, follow up with the dietitian should be conducted to achieve the overall goal-a relaxed FODMAP restriction that enables inclusion of prebiotic FODMAPs while still maintaining symptom relief. The diet will be effective in the vast majority of patients. For those in which it fails, FODMAPs should be reintroduced to the diet, and other dietary (or non-dietary) approaches should be considered.
引用
收藏
页码:8 / 10
页数:3
相关论文
共 21 条
[1]   No Effects of Gluten in Patients With Self-Reported Non-Celiac Gluten Sensitivity After Dietary Reduction of Fermentable, Poorly Absorbed, Short-Chain Carbohydrates [J].
Biesiekierski, Jessica R. ;
Peters, Simone L. ;
Newnham, Evan D. ;
Rosella, Ourania ;
Muir, Jane G. ;
Gibson, Peter R. .
GASTROENTEROLOGY, 2013, 145 (02) :320-+
[2]   Review article: the economic impact of the irritable bowel syndrome [J].
Canavan, C. ;
West, J. ;
Card, T. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (09) :1023-1034
[3]   Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome [J].
Chumpitazi, B. P. ;
Cope, J. L. ;
Hollister, E. B. ;
Tsai, C. M. ;
McMeans, A. R. ;
Luna, R. A. ;
Versalovic, J. ;
Shulman, R. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (04) :418-427
[4]   A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults [J].
Davis, L. M. G. ;
Martinez, I. ;
Walter, J. ;
Hutkins, R. .
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2010, 144 (02) :285-292
[5]   The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study [J].
de Roest, R. H. ;
Dobbs, B. R. ;
Chapman, B. A. ;
Batman, B. ;
O'Brien, L. A. ;
Leeper, J. A. ;
Hebblethwaite, C. R. ;
Gearry, R. B. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (09) :895-903
[6]   Diets that differ in their FODMAP content alter the colonic luminal microenvironment [J].
Halmos, Emma P. ;
Christophersen, Claus T. ;
Bird, Anthony R. ;
Shepherd, Susan J. ;
Gibson, Peter R. ;
Muir, Jane G. .
GUT, 2015, 64 (01) :93-100
[7]   Low FODMAP Diet in the Treatment of Irritable Bowel Syndrome: Is It the End of the Road or the Beginning of a Journey? Reply [J].
Halmos, Emma P. ;
Muir, Jane G. ;
Gibson, Peter R. .
GASTROENTEROLOGY, 2014, 146 (07) :1830-1831
[8]   Lactose Intolerance and the Role of the Lactose Breath Test [J].
Law, David ;
Conklin, Jeffrey ;
Pimentel, Mark .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (08) :1726-1728
[9]   Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis [J].
Lovell, Rebecca M. ;
Ford, Alexander C. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (07) :712-+
[10]   Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics [J].
Macfarlane, G. T. ;
Steed, H. ;
Macfarlane, S. .
JOURNAL OF APPLIED MICROBIOLOGY, 2008, 104 (02) :305-344